---
title: "US FDA approves LimFlow system for treatment of CLTI"
date: "2023-09-12T12:05:59.000Z"
publishedDate: "12 septembre 2023"
summary: "The US Food and Drug Administration (FDA) today announced approval of LimFlow therapy—a novel and minimally invasive procedure designed to bypass blockages in arteries of the legs and restore blood flow for many thousands of people suffering from chronic limb-threatening ischemia (CLTI). LimFlow’s FDA approval follows New England Journal of Medicine publication of results from the [&#8230;] The post US FDA approves LimFlow system for treatment of CLTI appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/us-fda-approves-limflow-system-for-clti-patients/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-09-12-us-fda-approves-limflow-system-for-treatment-of-clti"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/03/Vein-becoming-artery-with-LimFlow-crossing-stent.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/us-fda-approves-limflow-system-for-clti-patients/"
---

![US FDA approves LimFlow system for treatment of CLTI](https://vascularnews.com/wp-content/uploads/sites/7/2023/03/Vein-becoming-artery-with-LimFlow-crossing-stent.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/us-fda-approves-limflow-system-for-clti-patients/*

## L’essentiel

The US Food and Drug Administration (FDA) today announced approval of LimFlow therapy—a novel and minimally invasive procedure designed to bypass blockages in arteries of the legs and restore blood flow for many thousands of people suffering from chronic limb-threatening ischemia (CLTI). LimFlow’s FDA approval follows New England Journal of Medicine publication of results from the [&#8230;] The post US FDA approves LimFlow system for treatment of CLTI appeared first on Vascular News .

## Lien source

https://vascularnews.com/us-fda-approves-limflow-system-for-clti-patients/
